Search


Terray Therapeutics' CEO on designing computational and experimental platforms to supercharge small molecule discovery
Jacob Berlin walks on the process that has allowed Terray to do well over 2 billion target / ligand binding measurements over 18 months.
Jan 31, 2024






.png)
